Total submissions: 2
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Labcorp Genetics |
RCV002011011 | SCV002295915 | uncertain significance | Osteogenesis imperfecta type I; Ehlers-Danlos syndrome, classic type, 1 | 2021-06-08 | criteria provided, single submitter | clinical testing | This sequence change replaces proline with serine at codon 171 of the COL1A2 protein (p.Pro171Ser). The proline residue is highly conserved and there is a moderate physicochemical difference between proline and serine. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Not Available"; Align-GVGD: "Class C65"). This variant has not been reported in the literature in individuals with COL1A2-related conditions. This variant is not present in population databases (ExAC no frequency). |
| Victorian Clinical Genetics Services, |
RCV004785445 | SCV005399942 | uncertain significance | Osteogenesis imperfecta, perinatal lethal | 2021-05-06 | criteria provided, single submitter | clinical testing | Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as VUS-3B. Following criteria are met: 0103 - Dominant negative and loss of function are known mechanisms of disease in this gene. Heterozygous missense variants causing severe and lethal forms of osteogenesis imperfecta (MIM#s166210, 259420 & 166220) are due to a dominant negative mechanism, whereas biallelic loss of function variants result in the autosomal recessive form of Ehlers-Danlos syndrome (MIM#225320). The exact mechanism of disease for the autosomal dominant form of Ehlers-Danlos syndrome (MIM#2617821) remains unclear, however variants have been shown to result in the whole or partial skipping of exon 6 (PMID: 12362985, PMID: 31218159). (I) 0108 - This gene is associated with both recessive and dominant disease. Most phenotypes associated with this gene are autosomal dominant, however the cardiac valvular type of Ehlers-Danlos syndrome (MIM#225320) is recessively inherited (OMIM). (I) 0200 - Variant is predicted to result in a missense amino acid change from proline to serine. (I) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0501 - Missense variant consistently predicted to be damaging by multiple in silico tools or highly conserved with a major amino acid change. (SP) 0600 - Variant is located in the annotated collagen triple helix repeat, at the Y position of a Gly-X-Y motif (NCBI). (I) 0705 - No comparable missense variants have previous evidence for pathogenicity. (I) 0807 - This variant has no previous evidence of pathogenicity. (I) 0905 - No published segregation evidence has been identified for this variant. (I) 1007 - No published functional evidence has been identified for this variant. (I) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign |